PALUNIL TAB is a high-quality paracetamol-based tablet used for its dual function as an analgesic (pain reliever) and antipyretic (fever reducer). Each tablet is carefully formulated to deliver uniform and effective doses that work quickly to lower elevated body temperatures and relieve pain associated with common ailments such as headaches, toothaches, muscle aches, backaches, arthritis, and the discomforts of cold and flu.

Paracetamol, the active compound in PALUNIL TAB, works by inhibiting prostaglandin synthesis in the central nervous system and raising the body’s pain threshold. It also acts directly on the heat-regulating center of the brain to lower fever. With an excellent safety profile when used as directed, PALUNIL TAB is suitable for use by a wide range of patients including children (in adjusted doses), adults, and elderly individuals.

Manufactured by Bluepill Express in WHO-GMP certified facilities, PALUNIL TAB undergoes rigorous quality assurance processes that ensure batch-to-batch consistency, high bioavailability, and stability. The formulation is designed to dissolve rapidly in the stomach, offering quick symptomatic relief, and is well-tolerated with minimal side effects when taken as per prescribed dosage. It is available in multiple dosage strengths and packaging formats to accommodate various regional pharmaceutical markets and regulatory requirements.

PALUNIL TAB is a popular over-the-counter (OTC) medication in many countries, and also a critical inclusion in hospital treatment protocols for post-operative pain, viral infections, and other febrile conditions. Bluepill Express supports its global clients by offering private labeling services, branding customization, and comprehensive regulatory documentation including COA, MSDS, stability data, and CTD format dossiers.

As part of Bluepill Express’s extensive antipyretic and analgesic portfolio, PALUNIL TAB meets the needs of pharmacies, hospitals, clinics, and healthcare distributors who prioritize affordable and effective medicine. It complies with the pharmacopeial standards of IP, BP, and USP as required by the client’s export destination.

PALUNIL TAB should be taken with or without food, and patients are advised not to exceed the maximum daily dosage to avoid liver-related adverse effects. It should not be used concurrently with other paracetamol-containing products. Healthcare professionals recommend monitoring usage especially in pediatric and elderly populations, and in patients with pre-existing liver or kidney conditions.